<DOC>
	<DOCNO>NCT01305317</DOCNO>
	<brief_summary>This double blind randomize control trial statin effect serum IgG , IgA IgM level chronic hemodialysis patient Bandarabbas</brief_summary>
	<brief_title>Effect Statins IgG , IgA IgM Level Chronic Hemodialysis Patients</brief_title>
	<detailed_description>This study randomize control trial statin effect serum IgG , IgA IgM level chronic hemodialysis patient Bandarabbas . The study carry Hormozgan , Iran . Seventy four patient randomize either receive atorvastatin addition usual treatment . The primary outcome serum IgG , IgA IgM level . The secondary outcome drug side effect .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>All chronic hemodialysis patient attend Shahid Mohammadi hospital study period Accepting participate study Refusing participate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>Statin</keyword>
</DOC>